Genetic
Entry
2025
Hold
1yr
Status
Active
Who owns Genetic?
Genetic is currently owned by Renaissance Partners through Renaissance Partners Fund IV (2025 vintage), since 2025. Across its history, Genetic has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-21
Most recent investor
Renaissance PartnersRenaissance Partners Fund IV · 2025 · Mid-Large Buyout
2 ownership periods · full history below
Key facts
HQItaly
SectorPharma
StatusActive
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2025 · present
Aurora Growth CapitalActive
2025 · present(1yr) · Aurora Growth Capital (SICAV-RAIF) · 2018 · Growth
Renaissance PartnersActive
2025 · present(1yr) · Renaissance Partners Fund IV · 2025 · Mid-Large Buyout
More from Renaissance Partners Fund IV
Other portfolio companies in the same fund.
More Renaissance Partners portfolio companies
From the same investor, across funds.
More PE-backed in Pharma
Comparable pharma deals from other GPs.
Track Genetic
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Genetic?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Genetic.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue